Ribonuclease inhibitor interacts with integrin-linked kinase and inhibits bladder cancer growth<em>in vitro</em>and<em>in vivo</em>through ILK/AKT/mTOR pathway

邢　雷; 庄　翔; 陈俊霞

doi:10.19401/j.cnki.1007-3639.2018.01.004

您当前的位置：

首页 >

文章列表页 >

Ribonuclease inhibitor interacts with integrin-linked kinase and inhibits bladder cancer growthin vitroandin vivothrough ILK/AKT/mTOR pathway

更新时间：2026-01-27

- Ribonuclease inhibitor interacts with integrin-linked kinase and inhibits bladder cancer growthin vitroandin vivothrough ILK/AKT/mTOR pathway
- China Oncology Vol. 28, Issue 1, Pages: 30-37(2018)
- 作者机构：
  
  1. 重庆医科大学附属第一医院内分泌乳腺外科,重庆,400016
  2. 重庆医科大学细胞生物学与遗传学教研室,重庆,400016
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2018.01.004
  CLC： R737.14
- Published Online：07 February 2018，
  
  Published：07 February 2018
- 稿件说明：
移动端阅览
邢　雷,庄　翔,陈俊霞. 核糖核酸酶抑制因子与整合素连接激酶相互作用通过ILK/AKT/mTOR通路抑制膀胱癌体内外生长[J]. 中国癌症杂志, 2018, 28(1): 30-37.

邢　雷, 庄　翔, 陈俊霞. Ribonuclease inhibitor interacts with integrin-linked kinase and inhibits bladder cancer growthin vitroandin vivothrough ILK/AKT/mTOR pathway[J]. China Oncology, 2018, 28(1): 30-37.
邢　雷,庄　翔,陈俊霞. 核糖核酸酶抑制因子与整合素连接激酶相互作用通过ILK/AKT/mTOR通路抑制膀胱癌体内外生长[J]. 中国癌症杂志, 2018, 28(1): 30-37. DOI： 10.19401/j.cnki.1007-3639.2018.01.004.

邢　雷, 庄　翔, 陈俊霞. Ribonuclease inhibitor interacts with integrin-linked kinase and inhibits bladder cancer growthin vitroandin vivothrough ILK/AKT/mTOR pathway[J]. China Oncology, 2018, 28(1): 30-37. DOI： 10.19401/j.cnki.1007-3639.2018.01.004.

摘要

背景与目的：蛋白质相互作用控制着细胞信号转导、跨膜转运、DNA合成及转录调控等生命过程，在生命活动中发挥重要作用。前期运用GST蛋白沉降技术与免疫共沉淀等已证明核糖核酸酶抑制因子(ribonuclease inhibitor，RI)与整合素连接激酶(intergrin-linked kinase，ILK)在体内外直接结合。该研究旨在探讨RI与ILK相互作用对ILK/AKT/mTOR通路与膀胱癌体内外生长的影响。方法：采用免疫荧光观察RI与ILK在膀胱癌EJ细胞中的共定位。采用荧光共振能量转移技术(fluorescence resonance energy transfer，FRET)验证RI与ILK的相互作用。构建过表达RI或ILK的EJ细胞系。采用蛋白［质］印迹法(Western blot)检测细胞中RI、ILK及ILK/AKT/mTOR通路相关蛋白的表达。采用细胞计数试剂盒(cell counting kit-8，CCK-8)与流式细胞术分析细胞增殖与细胞周期。构建膀胱癌裸鼠移植瘤模型，观察过表达RI或ILK对移植瘤生长的影响。采用免疫组织化学与免疫荧光分析瘤组织中RI、ILK及ILK/AKT/mTOR通路相关蛋白的表达。结果：EJ细胞中RI与ILK存在共定位的现象且RI与ILK存在相互作用。过表达RI抑制EJ细胞增殖并导致细胞周期阻滞于S期(P0.05)，阻碍膀胱癌移植瘤的生长(P0.05)，并抑制体内外ILK/AKT/mTOR通路的活化(P0.05)。而过表达ILK促进细胞增殖与移植瘤的生长(P0.05)，促进体内外ILK/AKT/mTOR信号通路的激活(P0.05)。结论：RI通过与ILK相互作用阻碍ILK/AKT/mTOR通路激活并抑制膀胱癌体内外的增殖生长。

Abstract

Background and purpose: Protein interactions dominate the life processes

including cell signal transduction

transmembrane transport

DNA synthesis and transcriptional regulation

playing important and complex roles in life activities. Our previous study demonstrated the direct combination of ribonuclease inhibitor (RI) and integrin-linked kinase (ILK) in vitro and in vivo using GST pull down and Co-IP. The purpose of this study was to investigate the role of interplay between RI and ILK on ILK/AKT/mTOR pathway and bladder carcinoma growth in vitro and in vivo. Methods: Immunofluorescence staining was performed to analyze the co-localization of RI and ILK in bladder cancer EJ cells. Fluorescence resonance energy transfer (FRET) was applied to demonstrate the interaction between RI and ILK. Subsequently

the stable EJ cell lines with overexpression of RI or ILK were generated respectively. The protein levels of RI

ILK

and the molecules related to ILK/AKT/mTOR pathway were determined using Western blot. And the cell viability and cell cycle were analyzed by cell counting kit-8 (CCK-8) and flow cytometry assays respectively. In addition

the model of bladder cancer xenograft in nude mouse was constructed

and the effects of overexpression of RI or ILK on xenograft growth were observed. The expressions of RI

ILK and the proteins related to ILK/AKT/mTOR pathway in xenograft tissues were examined using immunohistochemistry and immunofluorescence. Results: The co-localization and interaction of RI and ILK were observed and verified in EJ cells. Overexpression of RI suppressed cell proliferation capacity (P0.05)

led to the blockage of S phase (P0.05)

repressed bladder cancer xenograft growth (P0.05)

and inhibited ILK/AKT/mTOR pathway in vitro and in vivo (P0.05). However

overexpression of ILK promoted cell proliferation and xenograft growth (P0.05)

and overactivated ILK/AKT/mTOR pathway in vitro and in vivo (P0.05). Conclusion: RI interacts with ILK

inhibits ILK/AKT/mTOR pathway and suppresses bladder cancer growth in vitro and in vivo.

关键词

Keywords

references

Views

1881

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

PRMT7 inhibits proliferation and migration of bladder cancer cells by regulating Notch signaling pathway

Mechanistic study on PLK4 regulation of invasion, proliferation and apoptosis in oral squamous cell carcinoma

PARP1 promotes the progression of hepatocellular carcinoma by regulating expression of POU2F2

Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)

Effects of TMCO1 on proliferation and migration of cervical cancer cells

Related Author

Xuemei WANG

Yu CHENG

Jiemin QI

Huan QIN

Jie WANG

Jie YANG

Yingjie HUA

Huijuan QU

Related Institution

Department of Pathology, Chengde Medical University

School of Stomatology, Shandong Second Medical University

Department of Stomatology, Affiliated Hospital of Shandong Second Medical University

Shouguang Stomatological Hospital

Department of Hepatobiliary Surgery, Linfen People’s Hospital, The Seventh Clinical Medical College of Shanxi Medical University

AI问答

⁰

Ribonuclease inhibitor interacts with integrin-linked kinase and inhibits bladder cancer growthin vitroandin vivothrough ILK/AKT/mTOR pathway

DOI：10.19401/j.cnki.1007-3639.2018.01.004

摘要

Abstract

关键词

Keywords

references